Eboo Versi, MD PhD
Founder & Chairman
Eboo has over 30 years of experience as a surgeon, academic physician researcher, teacher, entrepreneur, investor, and senior pharma executive.
He is the inventor on several patents, and owns multiple U.S. and international patents under the Versi Group and its licensees. Eboo has served as a pharmaceutical executive at several large (Pfizer, Astellas) and small (Pliva, Mt Cook) companies in a medical capacity culminating as Chief Medical Officer, and head of drug development.
Previously, he was the chief of service at the Brigham & Women’s Hospital and an Associate Professor at Harvard Medical School. Eboo has published over 100 scientific articles in a variety of fields. He is board certified having practiced in the US and EU and has held leadership positions in several national and international academic committees as well as serving on several ad hoc committees for the National Institutes of Health.
Eboo received his Masters and Doctorate from Oxford and Medical Degree from Cambridge in the UK.
Bina Julian, PhD
Bina has spent the last 10 years advancing pharmaceutical research at Pfizer, the Broad Institute of Harvard and MIT, and Tufts Medical Center.
Her projects, where she served both scientific and managerial roles, include the LINCS (Library of Integrated Network-based Cellular Signatures) L1000 Connectivity Map as well as the pharmacological analysis of several tyrosine kinases and GPCRs. At Boston Biomedical Consultants, her work focused on the Nucleic Acid Testing and the (then) emerging Biomarkers markets.
Bina completed her PhD in Pharmacology and Experimental Therapeutics at Tufts University, where she was also recognized with the Presidential Award for Citizenship and Public Service. She completed her MEng and BS in Biomedical Engineering at Cornell University, where she was recognized as a Knauss MEng Scholar. Bina serves as an advisor to the Tufts Biomedical Business Club, runs the South Bay Biotech Network and is a member of the Healthcare Businesswomen's Association.
Christopher Gilbert, PhD
Chief Operating Officer
Chris has worked in the pharmaceutical and medical device industries for 15+ years in a variety of executive roles.
He served as the CTO and SVP of Science and Technology at Keystone Dental, and was also responsible for west coast operations of the surgical instruments business at Cytyc, both before and after their acquisition by Hologic in 2008. He originally joined Cytyc as a Principal on their Corporate Development team, and came to Cytyc from McKinsey & Company, where he spent six years serving a variety of healthcare and technology-focused clients.
Chris completed his Masters and Doctorate at UC Berkeley, and his BS at Carnegie Mellon University.
On a personal note, Chris has struggled with the symptoms of Parkinson’s disease since late 2002. He recently benefited from deep-brain stimulation surgery, and understands first-hand the terrible impact of dyskinesia.
Jannine Versi, MBA
Strategy & Operations
Jannine's career spans healthcare, government, and technology. She has worked with a variety of innovative digital health and life sciences companies in strategic, operational, and business development capacities.
Previously, Jannine served as a senior executive in the Obama Administration and worked at the National Economic Council within the White House. Jannine was the chief of staff to the Under Secretary of Commerce for International Trade, helping to oversee a 2,200-person global team responsible for the U.S.' international trade and investment policy.
Jannine began her career as a healthcare investment banker and worked at Somnus Therapeutics, a venture-backed pharma company, before joining Google. There, she focused on strategy, operations, and product marketing in the U.S., U.K., and Middle East.
Jannine holds an MBA from Harvard Business School, a BA from the University of Pennsylvania, and was a Fulbright scholar in India.